January 2019 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2019. This roundup includes the latest research news from journal articles, as […]

Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

FDA Approves First Generic Version of Advair for Asthma, COPD

THURSDAY, Jan. 31, 2019 (HealthDay News) — The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.

More Information

No Asthma Benefit Seen With n3PUFA in Overweight Teens

WEDNESDAY, Jan. 30, 2019 (HealthDay News) — Omega-3 fatty acid (n3PUFA) supplements do not appear to improve asthma control in teens and young adults who are overweight or obese, according to a study published online Jan. 25 in the Annals of the American Thoracic Society.

Abstract/Full Text (subscription or payment may be required)

Report IDs Areas Lacking Good Practice in Health Tech Assessment

FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).

Abstract/Full Text (subscription or payment may be required)

FDA Down to 5 Weeks of Funding to Review New Drug Applications

THURSDAY, Jan. 17, 2019 (HealthDay News) — Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.

CNN News Article

Asthma Undiagnosed in One in Five Urban Adolescents

THURSDAY, Jan. 17, 2019 (HealthDay News) — The prevalence of undiagnosed asthma is 20.2 percent among urban adolescents, according to a study published online Jan. 15 in the Journal of Urban Health.

Abstract/Full Text (subscription or payment may be required)

Adoption of Advanced Health IT Capabilities Inconsistent

WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.

Abstract/Full Text

Review Shares Best Practices for Evaluating Penicillin Allergy

WEDNESDAY, Jan. 16, 2019 (HealthDay News) — A new review, published in the Jan. 15 issue of the Journal of the American Medical Association, addresses best practices for the evaluation and management of reported penicillin allergies.

Abstract/Full Text (subscription or payment may be required)

Study Explores Influence of Genetics, Environment in Disease

1 | 2 | 3
Page 1 of 3
Next »